Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations
Ole Haagen Nielsen, Alexander Hammerhøj, Mark Ainsworth, John Gubatan, Geert D’Haens
Topics & Concepts
MedicineImmunogenicityBiopharmaceuticalInfliximabIntensive care medicineDiseaseInflammatory bowel diseaseVedolizumabBiosimilarImmunologyDrugClinical trialImmune systemPharmacologyInternal medicineGeneticsBiologyInflammatory Bowel DiseaseBiosimilars and Bioanalytical MethodsMonoclonal and Polyclonal Antibodies Research